Telitacicept: A New Therapy for the Treatment of Optic Neuromyelitis Spectrum Disease Associated with Other Autoimmune Disorders
Shaomin Zuo,1 Wenning Yang,1 Siyu Zhang,2 Shuyue Sun,2 Songke Lu,2 Chengcheng Lu,1 Wei Li3 1Department of Neurology, People’s Hospital of Henan University, Zhengzhou, People’s Republic of China; 2Department of Neurology, People’s Hospital of Zhengzhou University, Zhengzhou, People’s Republic of Chin...
Saved in:
| Main Authors: | Zuo S, Yang W, Zhang S, Sun S, Lu S, Lu C, Li W |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2025-04-01
|
| Series: | Biologics: Targets & Therapy |
| Subjects: | |
| Online Access: | https://www.dovepress.com/telitacicept-a-new-therapy-for-the-treatment-of-optic-neuromyelitis-sp-peer-reviewed-fulltext-article-BTT |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy and safety of telitacicept in IgA nephropathy: a real-world study
by: Lingqiu Dong, et al.
Published: (2025-12-01) -
Dual BLyS/APRIL targeted therapy with telitacicept in rituximab-refractory SLE-associated neuromyelitis optica spectrum disorder: a case report
by: Mingfen Dai, et al.
Published: (2025-05-01) -
Consensus of expert advices on routing, diagnosis, and management of patients with neuromyelitis optica spectrum disorders
by: A. N. Boyko, et al.
Published: (2021-10-01) -
Anti-B-cell therapy in patients with neuromyelitis optica spectrum disorders
by: S. V. Kotov, et al.
Published: (2021-08-01) -
Neuromyelitis optica spectrum disorder in childhood (a case report)
by: A. S. Kotov, et al.
Published: (2018-01-01)